Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies

Autor: Nicolas Demartines, Tania Santoro, Seraina Faes, Olivier Dormond, Emilie Uldry, Anne Planche, Catherine Pythoud
Rok vydání: 2016
Předmět:
0301 basic medicine
Vascular Endothelial Growth Factor A
Indoles
Endothelium
endothelium
Angiogenesis
sunitinib
Down-Regulation
Angiogenesis Inhibitors
03 medical and health sciences
chemistry.chemical_compound
Mice
angiogenesis
0302 clinical medicine
Cell Movement
Medicine
Animals
Humans
Pyrroles
Protein kinase B
acidity
Cells
Cultured

Angiogenesis Inhibitors/therapeutic use
Cell Proliferation/drug effects
Endothelial Cells/physiology
Female
Hydrogen-Ion Concentration
Indoles/pharmacology
Mice
Inbred C57BL

Pyrroles/pharmacology
Sodium Bicarbonate/pharmacology
Vascular Endothelial Growth Factor A/pharmacology
Vascular Endothelial Growth Factor Receptor-2/antagonists & inhibitors
Vascular Endothelial Growth Factor Receptor-2/physiology
VEGF
Cell Proliferation
business.industry
Sunitinib
Endothelial Cells
Kinase insert domain receptor
Vascular Endothelial Growth Factor Receptor-2
3. Good health
Endothelial stem cell
Vascular endothelial growth factor
Vascular endothelial growth factor A
030104 developmental biology
medicine.anatomical_structure
Sodium Bicarbonate
Oncology
chemistry
030220 oncology & carcinogenesis
Immunology
Cancer research
business
medicine.drug
Research Paper
Zdroj: Oncotarget
Oncotarget, vol. 7, no. 52, pp. 86026-86038
ISSN: 1949-2553
Popis: // Seraina Faes 1 , Emilie Uldry 1 , Anne Planche 1 , Tania Santoro 1 , Catherine Pythoud 1 , Nicolas Demartines 1 , Olivier Dormond 1 1 Department of Visceral Surgery, University Hospital of Lausanne, Switzerland Correspondence to: Olivier Dormond, email: olivier.dormond@chuv.ch Keywords: acidity, VEGF, angiogenesis, sunitinib, endothelium Received: April 22, 2016 Accepted: November 06, 2016 Published: November 12, 2016 ABSTRACT Anti-angiogenic treatments targeting the vascular endothelial growth factor or its receptors have shown clinical benefits. However, impact on long-term survival remains limited. Solid tumors display an acidic microenvironment that profoundly influences their biology. Consequences of acidity on endothelial cells and anti-angiogenic therapies remain poorly characterized and hence are the focus of this study. We found that exposing endothelial cells to acidic extracellular pH resulted in reduced cell proliferation and migration. Also, whereas VEGF increased endothelial cell proliferation and survival at pH 7.4, it had no effect at pH 6.4. Furthermore, in acidic conditions, stimulation of endothelial cells with VEGF did not result in activation of downstream signaling pathways such as AKT. At a molecular level, acidity significantly decreased the expression of VEGFR-2 by endothelial cells. Consequently, anti-angiogenic therapies that target VEGFR-2 such as sunitinib and sorafenib failed to block endothelial cell proliferation in acidic conditions. In vivo , neutralizing tumor acidity with sodium bicarbonate increased the percentage of endothelial cells expressing VEGFR-2 in tumor xenografts. Furthermore, combining sodium bicarbonate with sunitinib provided stronger anti-cancer activity than either treatment alone. Histological analysis showed that sunitinib had a stronger anti-angiogenic effect when combined with sodium bicarbonate. Overall, our results show that endothelial cells prosper independently of VEGF in acidic conditions partly as a consequence of decreased VEGFR-2 expression. They further suggest that strategies aiming to raise intratumoral pH can improve the efficacy of anti-VEGF treatments.
Databáze: OpenAIRE